Product Information
BUSPIRONE HCL 30 MG TABLET is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.1222 per EA under NDC 75834027060. Its NADAC has been published 185 times since Aug 25, 2021.
FDA first approved this application on May 3, 2018. Its Orange Book therapeutic-equivalence code is BX.
Strength
30 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834027060
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
2/19/2025
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209696FDA Approved
5/3/2018
TE Code
BX
On Market Since
2/15/2021
Price Statistics
The NADAC for BUSPIRONE HCL 30 MG TABLET has been published 185 times since Aug 25, 2021, and over the history we have for it it has declined 49.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1222 per EA |
|---|---|
| All-time high | $0.2407 (Sep 15, 2021) |
| All-time low | $0.0971 (May 22, 2024) |
| Median price | $0.1436 |
| Average price | $0.1515 |
| Largest weekly change | +36.0% (Jun 19, 2024) |
| Weeks tracked | 185 |
| Tracking since | Aug 25, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-14.9%
5Y
N/A
All
-49.2%
Last surveyed Mar 5, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 30 MG TABLET, manufactured by Nivagen Pharmaceuticals Inc., is $0.1222 per EA (NDC 75834027060), effective Mar 5, 2025.
How has the price of BUSPIRONE HCL 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 30 MG TABLET has declined 49.2%. It has been tracked across 185 weekly CMS publications since Aug 25, 2021.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 30 MG TABLET?
Since Aug 25, 2021, the NADAC for BUSPIRONE HCL 30 MG TABLET has ranged from a low of $0.0971 (May 22, 2024) to a high of $0.2407 (Sep 15, 2021), with a median of $0.1436 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 30 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUSPIRONE HCL 30 MG TABLET, is $0.1117 per EA — about 9% below BUSPIRONE HCL 30 MG TABLET.
Who manufactures BUSPIRONE HCL 30 MG TABLET?
BUSPIRONE HCL 30 MG TABLET (NDC 75834027060) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.